Skip to main content
Industrial Research And Consultancy Centre
Patent
3D-Printing of Scaffold Constructs for Patient Specific Regenerative Medicine and in Vitro Disease Models
Abstract

This invention presents a novel, patient-specific 3D printed porous gel composite scaffold developed using a cryogenic extrusion-based method. It combines gelatin, carboxymethyl chitin (CMC), and hydroxyapatite (HA) to create biocompatible, biodegradable, and osteoconductive scaffolds. The technology enables multiscale control over scaffold structure-customized outer shape, gradient macro-architecture, and sub-micron porosity-without relying on synthetic growth factors. The use of programmable G-code allows creation of graded porosity in multiple directions, mimicking natural bone’s complexity.

Figure (A–C) Customized 3D gel printing setup with heated syringe, air pressure system, and cryogenic build plate; (D) Printed scaffold; (E) Illustration of its compressibility

Problem Statement

Current bone graft methods-autografts, allografts, and synthetic substitutes-suffer limitations like donor site morbidity, immune rejection, disease transfer, and poor integration. There is a pressing need for a customizable, biocompatible scaffold that mimics natural bone morphology, supports cell growth, and is applicable to irregular defects.

Uniqueness of the Solution
  • Hierarchical Morphology Control: The scaffold design allows control over the outer shape, internal pore structure, and surface roughness, closely mimicking natural bone architecture. 
  • Gradient Porosity via Python-Coded G-Code: Custom Python-generated G-code enables gradient porosity in multiple directions, replicating the natural transition from dense to porous bone. 
  • Cryogenic Gel Extrusion Printing: The gel is printed onto a cold surface in a nitrogen-cooled environment, which instantly freezes it and preserves structural integrity. 
  • Material Composition Mimicking ECM: Natural polymers like gelatin and CMC simulate the extracellular matrix, while hydroxyapatite adds strength and supports bone cell growth. 
  • No Heat-Based Post Processing: Instead of using heat, lyophilization is employed to create micro-porosity and maintain the scaffold’s bioactivity.
Prototype Details

The system consists of a custom-modified commercial 3D printer fitted with a CAD-designed aluminum block heater and syringe holder, cryogenic cooling unit, and Python-generated G-code printing algorithm. Scaffolds up to 27 mm diameter × 10 mm height were successfully fabricated and tested.

Current Status of Technology

The technology is currently undergoing preclinical trials.

Technology readiness level

4

Societal Impact

This scaffold platform provides a cost-effective, scalable, and customizable bone graft alternative that eliminates need for secondary surgical sites and reduces healing time. It improves access to personalized treatment in orthopedics and dentistry, especially in resource-constrained settings.

Applications or Domain
  • Orthopedics: Treatment of complex and irregular bone defects 
  • Craniofacial Surgery: Personalized reconstruction of maxillofacial structures 
  • Dental Implants: Alveolar bone grafting in periodontics and prosthodontics 
  • Regenerative Medicine: Scaffold-based tissue regeneration platforms 
  • Medical Device Manufacturing: Biofabrication of implantable scaffolds 
  • 3D Bioprinting Industry: Customizable, patient-specific scaffold production

Geography of IP

Type of IP

Application Number

201721037191

Filing Date
Grant Number

382552

Grant Date
Assignee(s)
Indian Institute of Technology Bombay
**This IP is owned by IIT Bombay**